Literature DB >> 27026436

The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ.

Marquita R Decker1, Amy Trentham-Dietz2,3, Noelle K Loconte3, Heather B Neuman4, Maureen A Smith2, Rinaa S Punglia5, Caprice C Greenberg4, Lee G Wilke4.   

Abstract

BACKGROUND: Re-excision surgeries for the treatment of ductal carcinoma in situ (DCIS) put a strain on patients and healthcare resources; however, intraoperative pathologic assessment of DCIS may lead to a reduction in these additional surgeries. This study examined the relationship between intraoperative pathologic assessment and subsequent operations in patients with a diagnosis of DCIS.
METHODS: Surveillance, Epidemiology, and End Results-Medicare patients diagnosed with DCIS from 1999 to 2007 who initially underwent partial mastectomy, without axillary surgery, were included in this study. Use of intraoperative frozen section or touch preparation during the initial surgery was assessed. Multivariable logistic regression was used to describe the relationship between the use of intraoperative pathologic assessment and any subsequent mastectomy or partial mastectomy within 90 days of the initial partial mastectomy.
RESULTS: Of 8259 DCIS patients, 3509 (43 %) required a second surgery, and intraoperative pathologic assessment was performed for 2186 (26 %). Intraoperative pathologic assessment had no statistically significant effect on whether or not a subsequent breast surgery occurred (adjusted odds ratio 1.07, 95 % confidence interval 0.95-1.21; p = 0.293). Patient residence in a rural area, tumor size ≥2 cm, and poorly differentiated tumor grade were associated with a greater likelihood of subsequent surgery, while age 80 years and older was associated with a lower likelihood of subsequent surgery.
CONCLUSIONS: The use of intraoperative frozen section or touch preparation during partial mastectomy from 1999 to 2007 was not associated with a reduction in subsequent breast operations in women with DCIS. These results highlight the need to identify cost-effective tools and strategies to reduce the need for additional surgery in patients with DCIS.

Entities:  

Mesh:

Year:  2016        PMID: 27026436      PMCID: PMC4974137          DOI: 10.1245/s10434-016-5192-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

1.  A reality check for overdiagnosis estimates associated with breast cancer screening.

Authors:  Ruth Etzioni; Jing Xia; Rebecca Hubbard; Noel S Weiss; Roman Gulati
Journal:  J Natl Cancer Inst       Date:  2014-10-31       Impact factor: 13.506

2.  Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010.

Authors:  Lee G Wilke; Tomasz Czechura; Chih Wang; Brittany Lapin; Erik Liederbach; David P Winchester; Katharine Yao
Journal:  JAMA Surg       Date:  2014-12       Impact factor: 14.766

3.  Variability in reexcision following breast conservation surgery.

Authors:  Laurence E McCahill; Richard M Single; Erin J Aiello Bowles; Heather S Feigelson; Ted A James; Tom Barney; Jessica M Engel; Adedayo A Onitilo
Journal:  JAMA       Date:  2012-02-01       Impact factor: 56.272

4.  Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.

Authors:  Nicolien T van Ravesteyn; Diana L Miglioretti; Natasha K Stout; Sandra J Lee; Clyde B Schechter; Diana S M Buist; Hui Huang; Eveline A M Heijnsdijk; Amy Trentham-Dietz; Oguzhan Alagoz; Aimee M Near; Karla Kerlikowske; Heidi D Nelson; Jeanne S Mandelblatt; Harry J de Koning
Journal:  Ann Intern Med       Date:  2012-05-01       Impact factor: 25.391

5.  Accuracy of intraoperative frozen-section analysis of breast cancer lumpectomy-bed margins.

Authors:  Juan C Cendán; Dominique Coco; Edward M Copeland
Journal:  J Am Coll Surg       Date:  2005-08       Impact factor: 6.113

6.  Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery.

Authors:  Michael S Sabel; Julie M Jorns; Angela Wu; Jeffrey Myers; Lisa A Newman; Tara M Breslin
Journal:  Am J Surg       Date:  2011-12-16       Impact factor: 2.565

Review 7.  Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review.

Authors:  Karla Esbona; Zhanhai Li; Lee G Wilke
Journal:  Ann Surg Oncol       Date:  2012-07-31       Impact factor: 5.344

8.  Intraoperative margin assessment and re-excision rate in breast conserving surgery.

Authors:  F J Fleming; A D K Hill; E W Mc Dermott; A O'Doherty; N J O'Higgins; C M Quinn
Journal:  Eur J Surg Oncol       Date:  2004-04       Impact factor: 4.424

9.  Rapid noninvasive optical imaging of tissue composition in breast tumor margins.

Authors:  Lee G Wilke; J Quincy Brown; Torre M Bydlon; Stephanie A Kennedy; Lisa M Richards; Marlee K Junker; Jennifer Gallagher; William T Barry; Joseph Geradts; Nimmi Ramanujam
Journal:  Am J Surg       Date:  2009-10       Impact factor: 2.565

Review 10.  Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Authors:  C Correa; P McGale; C Taylor; Y Wang; M Clarke; C Davies; R Peto; N Bijker; L Solin; S Darby
Journal:  J Natl Cancer Inst Monogr       Date:  2010
View more
  6 in total

Review 1.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

2.  The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ.

Authors:  Michaela Semeraro; Julien Adam; Gautier Stoll; Emilie Louvet; Kariman Chaba; Vichnou Poirier-Colame; Allan Sauvat; Laura Senovilla; Erika Vacchelli; Norma Bloy; Juliette Humeau; Aitziber Buque; Oliver Kepp; Laurence Zitvogel; Fabrice André; Marie-Christine Mathieu; Suzette Delaloge; Guido Kroemer
Journal:  Oncoimmunology       Date:  2016-08-18       Impact factor: 8.110

Review 3.  Label-free optical imaging technologies for rapid translation and use during intraoperative surgical and tumor margin assessment.

Authors:  Stephen A Boppart; J Quincy Brown; Camile S Farah; Esther Kho; Laura Marcu; Christobel M Saunders; Henricus J C M Sterenborg
Journal:  J Biomed Opt       Date:  2017-12       Impact factor: 3.170

4.  Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.

Authors:  Leslie R Lamb; Sarah Mercaldo; Tawakalitu O Oseni; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-09-10       Impact factor: 5.344

5.  Diagnostic Accuracy of Cross-Polarization OCT and OCT-Elastography for Differentiation of Breast Cancer Subtypes: Comparative Study.

Authors:  Ekaterina V Gubarkova; Elena B Kiseleva; Marina A Sirotkina; Dmitry A Vorontsov; Ksenia A Achkasova; Sergey S Kuznetsov; Konstantin S Yashin; Aleksander L Matveyev; Aleksander A Sovetsky; Lev A Matveev; Anton A Plekhanov; Alexey Y Vorontsov; Vladimir Y Zaitsev; Natalia D Gladkova
Journal:  Diagnostics (Basel)       Date:  2020-11-24

6.  Diallyl Trisulfide Induces Apoptosis in Breast Ductal Carcinoma In Situ Derived and Minimally Invasive Breast Cancer Cells.

Authors:  Silvia D Stan; Minna Abtahi
Journal:  Nutrients       Date:  2022-03-31       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.